FDA Warns Homeopathic Firms for Putting Patients at Risk with Significant Violations of Manufacturing Quality Standards

The U.S. Food and Drug Administration today posted warning letters to four companies who produce homeopathic drug products for significant violations of current good manufacturing practice (CGMP) regulations, including a letter to King Bio Inc. of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news